Effects of DPP4 Inhibitors as Neuroprotective Drug on Cognitive Impairment in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis and Systematic Review

Figure 6

Meta-analysis of the impact of DPP4i on 2-hour postprandial glucose. Forest map showing the difference in 2-hour postprandial glucose variations with diabetes treated or not treated with DPP4i in five trials (n = 542). Black squares indicate mean differences, horizontal lines through black squares indicate 95% CI, and green diamonds indicate pooled effect sizes shown using a fixed-effect Hedges model.